CPT 38221 Bone Marrow Biopsy Billing: The 2026 Coding Decision Guide

Schedule Your Free Consultation

Why the physician can perform a flawless bone marrow biopsy and the claim can still fail — and how to catch it before submission.

Quick Answer:  CPT 38221 reports a diagnostic bone marrow biopsy (one or more) using a trephine or core needle. When a biopsy and an aspiration are both performed at the same site during the same encounter — the most common scenario — the combined code 38222 applies instead, not 38220 and 38221 billed together. That single distinction is the most common source of 38221 coding errors.

Key Takeaways

•     38220 = aspiration(s) only; 38221 = biopsy(ies) only; 38222 = biopsy and aspiration together, same site, same session.

•     Per current NCCI guidance, 38220 and 38221 should not both be billed for the same site and encounter — use 38222 instead.

•     38220 and 38221 can legitimately be billed together only when performed at different anatomical sites or separate encounters, with modifier 59 (or an appropriate X-modifier) supporting the distinction.

•     Each of 38220 and 38221 is reported once per encounter, even if multiple aspirations or biopsy passes were performed at the same insertion site.

•     The procedure code and the pathology interpretation (commonly 88305) are separate, distinct services.

•     A diagnosis code copied from a lab requisition or problem list — without support in the physician's own documentation — is a recognized denial trigger.

Start With the Clinical Event, Then Choose the Code

Correct CPT selection starts with what actually happened clinically, not with a habitual coding pattern. Was only an aspiration performed? Only a biopsy? Both, at the same site, same session? Both, but at different sites or different encounters? Each answer points to a different code, and the physician's procedure note — not a coder's assumption — has to establish which scenario occurred.

The CPT 38221 Coding Decision Table

 CPT 38221 vs. 38220 vs. 38222

Code	Procedure	Common Error
38220	Diagnostic bone marrow aspiration(s).	Billed alongside 38221 for the same site/session instead of using 38222.
38221	Diagnostic bone marrow biopsy(ies).	Billed as if it includes aspiration, when only a biopsy was performed.
38222	Diagnostic bone marrow biopsy(ies) and aspiration(s), same session.	Overlooked in favor of billing 38220 and 38221 separately.

Common Mistake:  Billing 38220 and 38221 together for a biopsy and aspiration performed at the same site during the same encounter. Per current NCCI guidance, that combination should be reported as 38222 instead — modifier 59 does not make the 38220/38221 pairing appropriate in that scenario.

What CPT 38221 Does — and Does Not — Represent

38221 covers the procedural service of obtaining the biopsy specimen. It does not include the pathologist's interpretation of that specimen (commonly reported separately, such as under 88305), nor does it automatically include flow cytometry, cytogenetic, or molecular testing performed on the specimen. Whether those associated services are separately reportable depends on who performed them, what was actually done, and the applicable payer's bundling and NCCI rules — not an assumption that everything related to the procedure is bundled together.

Documentation That Makes a 38221 Claim Defensible

•     Clinical indication and medical necessity for the biopsy.

•     Procedure performed — biopsy, aspiration, or both — stated explicitly, not implied.

•     Anatomical site, including laterality when relevant.

•     Specimen obtained and handling.

•     Complications, if any, and patient tolerance.

•     Physician authentication.

Exact documentation expectations can vary by payer — verify specific requirements rather than assuming one template covers every claim.

NCCI and Bundling: What Billing Teams Need to Check

Under current NCCI Policy Manual guidance, 38221 (biopsy) and 38220 (aspiration) form a code-edit pair when performed at the same site during the same encounter — the standard scenario should be billed as 38222, not the two codes together. Modifier 59 (or an appropriate X-modifier such as XS) is acceptable only when the biopsy and aspiration genuinely occurred at separate anatomical sites or separate patient encounters. Modifier 59 should never be added simply to force a claim past an edit when the clinical circumstances don't support genuine separation.

Connecting Diagnosis to Procedure

A diagnosis code copied from a lab requisition or an active problem list — without support in the physician's own documentation of that encounter — is a common source of denials, even when the procedure itself was performed and coded correctly. The ICD-10-CM code on the claim has to be traceable to what the physician actually documented as the clinical indication.

Expert Insight:  A denial doesn't always mean the procedure was billed incorrectly — it can mean the diagnosis code on the claim doesn't match what the note actually supports. Those are different root causes and need different fixes.

The Clinical-to-Coding-to-Claim Chain

•     Clinical indication documented by the physician.

•     Procedure identification — aspiration, biopsy, or both, and at what site(s).

•     CPT selection matched to the decision table above.

•     ICD-10-CM linkage traceable to the physician's documentation.

•     NCCI/edit review before submission, not after denial.

•     Modifier review — only applied where genuinely supported.

•     ERA/payment analysis after adjudication, comparing paid amount to the contracted rate.

Common CPT 38221 Claim Failure Scenarios

Revenue Leakage Beyond Denials

Leak	Why It Happens	Detection
Underpayment	Paid amount doesn't match the contracted rate.	Compare allowed vs. contracted amount on every remittance.
Missing charges	Biopsy performed but not captured on the claim.	Reconcile the procedure log against submitted charges.
Coding inconsistency	Same clinical scenario coded differently across providers.	Periodic coding pattern review across the practice.

CPT 38221 Revenue Cycle KPI Scorecard

KPI	What It Reveals
Denial Rate (38221-specific)	Whether coding and documentation controls are working for this procedure.
Coding Error Rate	How often the billed code matches the documented clinical scenario.
Underpayment Rate	Whether paid claims are actually checked against contracted rates.
Days in AR	How quickly billed charges convert to collected revenue.

Medicare vs. Commercial Payers: What to Verify

Coverage policy, prior authorization requirements, modifier acceptance, and documentation expectations for bone marrow biopsy claims can differ between Medicare, Medicare Advantage, Medicaid, and commercial payers. Verify the applicable payer's current policy rather than assuming Medicare rules apply universally.

Why a Single “National Rate” Is Misleading

Payment for CPT 38221 varies by payer contract, geography, place of service (professional vs. facility billing), and the specific claim circumstances. Rather than relying on a published national average, compare the allowed amount on each remittance against your practice's actual contracted rate to understand real effective reimbursement.

CPT 38221 Payment Accuracy Audit

1.   Pull 6–12 months of 38221-related claims.

2.   Segment by payer.

3.   Compare billed, allowed, and paid amounts.

4.   Review documentation against the code billed for each claim.

5.   Identify recurring root causes across denials and underpayments.

6.   Implement corrective workflow changes based on the pattern found.

Five Questions Every Hematology Practice Should Ask

1.   Are we coding what was actually performed — not a habitual default?

2.   Are our diagnosis codes supported by the physician's own documentation?

3.   Are we catching NCCI issues before submission, not after denial?

4.   Are we reviewing payments, not just denials, for underpayment patterns?

5.   Can we actually quantify the revenue leakage tied to this code?

How MedCloudMD Approaches CPT 38221 Revenue Integrity

MedCloudMD's hematology billing team works on the areas covered in this guide — 38220/38221/38222 coding accuracy, NCCI validation, documentation review, denial prevention, and payment variance analysis — with certified coders and human review built into the workflow.

Request a CPT Coding & Revenue Cycle Assessment:  If you're not sure how your practice's bone marrow biopsy claims are actually performing, our specialists can review your workflow with you.

Explore our Hematology & Oncology Billing Services, or talk with our billing specialists about your current 38221 workflow.

Frequently Asked Questions

What is CPT 38221?

CPT 38221 reports a diagnostic bone marrow biopsy — one or more — performed using a trephine or core needle, without an aspiration also being billed separately for the same site and session.

What is CPT 38221 used for?

It's used to report the procedural work of obtaining a bone marrow biopsy specimen for diagnostic evaluation, typically for conditions like unexplained cytopenias, suspected leukemia, or lymphoma staging.

What is the difference between CPT 38221 and 38220?

38221 reports the biopsy alone; 38220 reports the aspiration alone. When both are performed at the same site during the same encounter, neither is billed alone — 38222 applies instead.

When should CPT 38222 be reported?

When a biopsy and an aspiration are both performed at the same anatomical site during the same patient encounter — the most common real-world scenario for this procedure.

Can CPT 38220 and 38221 be reported together?

Only when the aspiration and biopsy are performed at different anatomical sites or during separate patient encounters, supported by documentation and an appropriate modifier. For same-site, same-session procedures, use 38222 instead.

What documentation is needed for CPT 38221?

Clinical indication, the specific procedure performed (biopsy, aspiration, or both), anatomical site, specimen handling, and physician authentication — exact requirements can vary by payer.

Does CPT 38221 require prior authorization?

Requirements vary by payer and plan — verify the applicable payer's current policy before the procedure rather than assuming authorization is or isn't needed.

Why are CPT 38221 claims denied?

Common causes include billing 38220 and 38221 together for a same-site/same-session procedure instead of using 38222, diagnosis codes that don't match physician documentation, and unsupported modifier 59 use.

How can a practice audit CPT 38221 payments?

By pulling several months of claims, segmenting by payer, comparing billed/allowed/paid amounts, and reviewing documentation against the code billed to identify recurring root causes.

Last Reviewed: August 2026. CPT® coding guidance, CMS/NCCI policy, and payer rules are updated periodically — this page will be reviewed as those change.

Disclaimer: This content is provided for educational and informational purposes only and should not be considered legal, coding, reimbursement, or medical advice. Billing regulations, CPT® coding, CMS/NCCI policies, and payer requirements may change over time and can vary by payer and location. Healthcare providers should verify current coding guidelines and reimbursement policies with the appropriate payer, CMS, AMA CPT® resources, or qualified coding professionals before submitting claims. MedCloudMD provides professional medical billing and revenue cycle management services to support healthcare organizations but does not guarantee reimbursement outcomes.